In 2006 was created Aitua Ltd, which is appeared as VC. The leading representative office of defined VC is situated in the Cambridge. The company was established in Europe in United Kingdom.
The typical case for the fund is to invest in rounds with 4 participants. The meaningful sponsors for the fund in investment in the same round are UK Innovation & Science Seed Fund, Sofinnova Partners, Avlar BioVentures. In the next rounds fund is usually obtained by Sofinnova Partners, Imperial Innovations, Astellas Venture Management.
The fund is generally included in less than 2 deals every year. The top activity for fund was in 2009. The usual things for fund are deals in the range of 5 - 10 millions dollars.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Crescendo Biologics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the most successful fund investment fields, there are Therapeutics, Health Care.
Fund Name | Location |
Acorn Ventures | Bellevue, United States, Washington |
BellSouth | Atlanta, Georgia, United States |
Blue Vector Systems | California, Mountain View, United States |
Dreamworx | - |
Emerging Ventures Seed Fund | Kentucky, Owensboro, United States |
Expanso Capital | Aquitaine, Bordeaux, France |
Gateway | California, Irvine, United States |
HH SPR-XV HK Holdings | China, Hong Kong, Hong Kong Island |
HOTventures | Arizona, Tucson, United States |
Moriah Energy Investments | - |
NEVEQ | Bulgaria, Grad Sofiya, Sofia |
NGEN Partners | New York, New York, United States |
Nueterra Capital | Kansas, Leawood, United States |
Shunya International | Beijing, Beijing, China |
Tata Sons Ltd | India, Maharashtra, Mumbai |
Trade Me | New Zealand, Wellington, Wellington |
V.S.T. Tillers Tractors Ltd | Bengaluru, India, Karnataka |
Washington Mutual | California, United States, Virginia |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Crescendo Biologics | $6M | 12 Oct 2009 | England |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Crescendo Biologics | $6M | 12 Oct 2009 | England |